In honor of March Madness, The Motley Fool's health-care team has assembled its own bracket consisting of the 16 largest pharmaceutical and biotech stocks on the market. The series gets under way with a tough matchup between two struggling giants of the pharmaceutical industry: AstraZeneca (AZN -0.55%) and Merck (MRK -0.13%). To learn the bull and bear cases for each stock -- and to see which stock will move on to the Elite Eight -- watch the following video.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.